Approval · Notice of Compliance 14101 · 2013
CITALOPRAM TABLETS: Notice of Compliance 14101
Issued February 14, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14101
- Date
- February 14, 2013
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antidepressant
- Canadian reference product
- CELEXA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CITALOPRAM TABLETS | 02400316 | — |
| CITALOPRAM TABLETS | 02400324 | — |
| CITALOPRAM TABLETS | 02400332 | — |
Medicinal ingredients
- CITALOPRAM HYDROBROMIDE 10 MG per TAB
- CITALOPRAM HYDROBROMIDE 20 MG per TAB
- CITALOPRAM HYDROBROMIDE 40 MG per TAB